Oslo Cancer Cluster

Det skolefaglige samarbeidet mellom Oslo Cancer Cluster og Ullern videregående skole bærer frukter: Marie er tidligere elev og tok del i en rekke utplasseringer, og er nå ferdig utdannet bioteknolog 👏

Join the second Nordic Lung Cancer Symposium on September 26th, and participate in discussions with experts as they frame the challenges of lung cancer and address clinical models for risk prediction, early diagnosis and screening plans in the Nordics.  In collaboration with Sykehuset Levanger Helse Nord-Trøndelag HF and Norges teknisk-naturvitenskapelige universitet (NTNU). The event is sponsored by AstraZeneca and Daiichi Sankyo Europe GmbH, Read more and sign up:

Last days to get the early bird rate at Nordic Life Science Days! Oslo Cancer Cluster has traditionally coordinated “The Norwegian Pavilion” at NLS Days annually. The Norwegian Pavilion provides a joint presence and forum featuring Norwegian Stakeholders in the life sciences. Join NLS Days 18. and 19. September, and meet up with Oslo Cancer Cluster (OCC), OCC members, and fellow Norwegian stakeholders. Read more and register here: https://lnkd.in/deZinEYr

I Oslo Cancer Cluster Innovasjonspark ved Radiumhospitalet ligger Ullern videregående skole, en av Oslos meste ettertraktede og kjente skoler. I 2019 fikk skolen et nytt studieprogram; Forskerlinjen. Dette studieprogrammet er derimot ikke like kjent, selv om den er den eneste av sitt slag i Oslo. Les hele saken her:

Working with cancer drug innovation and/or clinical trials in Norway? Then our webinar this upcoming Thursday (27/6) might be of interest: Webinar: Funding opportunities for clinical development of novel cancer drug innovations through CRUK/NCS partnership The Norwegian Cancer Society (Kreftforeningen) recently entered into a partnership with Cancer Research UK (CRUK) Centre for Drug Development (CDD) to co-fund early clinical development of promising cancer drug innovations (https://lnkd.in/dKdFD6iW). This funding program is aimed at academic and commercial developers with bold ideas that address high unmet patient needs. The partnership also aims to include Norwegian clinical trial sites, bringing new treatment opportunities to Norwegian patients. In this webinar on Thursday 27th June, 13.00-14.00, you will hear more about the partnership and the programme from CRUK Centre for Drug Development: 🔸Welcome and short intro by Sigrid Bratlie, Strategic Advisor at The Norwegian Cancer Society 🔸Presentation of CRUK CDD and the funding programme by Sophie Piper, Business Development Manager and Robert Williams, Chief Drug Development Scientist 🔸Q&A This webinar is open to all interested parties from the medical community, (innovators, clinicians, regulators etc). If interested drop me a note and I’ll send you the meeting link. Ingrid Stenstadvold Ross Kjetil Tasken Ketil F. Widerberg Jonas Einarsson Simen G. Enger Sophie Piper

📢 Don’t forget to join us June 26, from 15:00 CET, on the next #ECHoS practitioner community series webinar that will focus on how NCMHs can reflect, explore, and strategise their #Engagement with the wider public, #Communities, and #CivilSociety, leveraging their unique strengths and how to bring them to the table. Register now 👉 https://lnkd.in/dJ9pGaSH #CancerMissionHubs #Webinar #MissionCancer #EUmissions #HorizonEU European Commission European Health and Digital Executive Agency (HaDEA) EU Health and Food Safety Dheepa Rajan Florian Tille Rachel Greenley European Observatory on Health Systems and Policies World Health Organization

Ny utlysning fra Kreftforeningen! Den heter kvalifikasjonsprosjekter. Her kan ideer fra tidligere finansierte forskningsprosjekter få støtte i den aller tidligste fasen. 💡 Ideen kan være alt fra produkter til nye innovative tjenester, og midlene skal primært brukes til frikjøp av tid til innledende undersøkelser og avklaring for videre veivalg.   👨🔬 Forskningsinstitusjoner, TTO-er og private bedrifter kan søke midler   💰 Det lyses ut 8 millioner kroner til kvalifiseringsprosjekter. Hvert prosjekt kan tildeles 200 000-500 000 kroner over 3-12 måneder   ⏳ Søknadsfrist er tirsdag 15. oktober 2024, klokken 13:00  

Join the 30th-anniversary edition of BIO-Europe, which will take place November 4-6, 2024 in Stockholm, Sweden. The 30th annual BIO-Europe will convene over 5,500 life science professionals representing over 2,800 companies from over 60 countries. Sign up before July 26th to save with the Early Bird registration:

Are you looking for investment and want to optimize your IP protection story for potential investors? The ‘Investor Readiness Webinar Series 2024’ is part of a collaboration between five clusters within health- and life science aiming to provide increased knowledge of & readiness for the investor universe. 📅 Date: 29.08.2024 🕐 Time: 13:00 – 14:00 CET The Life Science Cluster, Norway Health Tech, Norwegian Smart Care Cluster, Oslo Cancer Cluster, Biotech North, and with supportive partners Inven2, VIS, Aleap, ShareLab, Aggrator, Eitri, Veksthuset for verdiskaping – UiO Growth House, Oslo universitetssykehus, SPARK. Read more and sign up: